Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions
Primary Purpose
Deep Caries
Status
Completed
Phase
Phase 3
Locations
Egypt
Study Type
Interventional
Intervention
biodentine
glass ionomer cement
DigoraH optium
Sponsored by
About this trial
This is an interventional health services research trial for Deep Caries
Eligibility Criteria
Inclusion Criteria:
- Patients male or female older than 18 y in good general health
- A minimum of 1 deep carious lesion penetrating three-quarters or more into the dentine as identified with the periapical (PA) radiograph; Clinically according to International Caries Detection and Assessment System (ICDAS II) score 4
- Clinical symptoms of reversible pulpitis
- Positive pulp response to electric pulp test or thermal stimulation
- No PA changes viewed on PA radiograph
Exclusion Criteria:
- Clinical symptoms of irreversible pulpitis requiring endodontic treatment
- Presence of fistulas or swelling
- Mobile teeth or tenderness to percussion
- Anterior teeth with aesthetic concerns
- Pregnant women, in view of requirements for radiographs
- Patients younger than 18 y
- Patients unable to give consent
Sites / Locations
- Omnia Magdy
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
biodentine
glass ionomer cement
Arm Description
bioactive dentin substitute used to act like natural dentin in insulating the pulp against external stimuli intervention
high viscosity glass ionomer used as a base material comparator other name : - fuji ix
Outcomes
Primary Outcome Measures
postoperative hypersensitivity using yes or no questionnaire
Secondary Outcome Measures
Biocompatibility of biodentine using digital X-ray
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02868918
Brief Title
Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions
Official Title
Clinical and Radiographical Evaluation of New Bioactive Dentine Substitute (Biodentine) Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions -Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
February 1, 2018 (Actual)
Primary Completion Date
January 1, 2019 (Actual)
Study Completion Date
March 1, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to compare the effect of new bioactive dentine substitute (Biodentine) versus glass ionomer cement in very deep carious lesions clinically and radiographically using digital radiography in the terms of postoperative pain and biocompatibility to the pulp.
Detailed Description
Roles and responsibilities:
Omnia Magdy Moustafa (O.M.) Operator, data entry & corresponding author; Assistant lecturer ,
Mohmed Riad Farid (M.R.) Main supervisor, data monitoring & auditing; Professor, Conservative Dentistry
Rasha Raffat (R.R.) Co-supervisor, data entry & auditing; Lecturer, Conservative Dentistry Department
Amir Hafez Ibrahim (A.H.), *Mohamed Refaat El-Bialy (M.E.) (A.H) Lecturer, Conservative Dentistry Department, Faculty of Oral & Dental Medicine Cairo University,(M.E.) Assistant lecturer , Conservative Dentistry Department, Faculty of Oral & Dental Medicine Cairo University outcome assessors and data collection.
Omar Shalaan (O.S.) Demonstrator, Conservative Dentistry Department, Faculty of Oral & Dental Medicine Cairo University, for baseline data collection, recruitment, sequence generation, allocation concealment, patient retention and taking participants consents.
Interventions:
Pre-operative clinical assessment :
Thermal testing using Refrigerant spray
percussion test
Palpation and clinical examination
peri-apical radiographs using digital radiograph
Caries removal procedure:
Local anesthesia will be given to the patient then complete isolation to the tooth using rubber dame the operator O.M. will open the enamel Then in caries removal from the walls carbon-steel rose-head bur. Finally the deeper caries will be removed using spoon excavator
Intervention : Biodentine™ (Septodont, St. Maur-des-Fossés, France) The material will be applied according to manufacturer instructions
Comparator: GC Fuji IX GP (GC America Inc, Alsip, IL, USA) The material will be applied according to manufacturer instructions
Final restoration application:
Filtek™ Z250 Universal Restorative (3M Canada, London, Ontario Canada)
-Adhesive system: Scotchbond Universal Etchant (3M ESPE, St. Paul MN, USA) & Single Bond Universal adhesive (3M ESPE, St. Paul MN, USA).
The material will be applied according to manufacturer instruction
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Deep Caries
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Arm Title
biodentine
Arm Type
Experimental
Arm Description
bioactive dentin substitute used to act like natural dentin in insulating the pulp against external stimuli intervention
Arm Title
glass ionomer cement
Arm Type
Active Comparator
Arm Description
high viscosity glass ionomer used as a base material comparator other name : - fuji ix
Intervention Type
Drug
Intervention Name(s)
biodentine
Other Intervention Name(s)
tricalcium silicate
Intervention Description
tricalcium silicate cement used to replace the carious dentin
Intervention Type
Drug
Intervention Name(s)
glass ionomer cement
Other Intervention Name(s)
Fuji ix
Intervention Description
high viscosity glass ionomer used as a base material
Intervention Type
Device
Intervention Name(s)
DigoraH optium
Other Intervention Name(s)
digital radiography
Intervention Description
digital Xray for follow up
Primary Outcome Measure Information:
Title
postoperative hypersensitivity using yes or no questionnaire
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Biocompatibility of biodentine using digital X-ray
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients male or female older than 18 y in good general health
A minimum of 1 deep carious lesion penetrating three-quarters or more into the dentine as identified with the periapical (PA) radiograph; Clinically according to International Caries Detection and Assessment System (ICDAS II) score 4
Clinical symptoms of reversible pulpitis
Positive pulp response to electric pulp test or thermal stimulation
No PA changes viewed on PA radiograph
Exclusion Criteria:
Clinical symptoms of irreversible pulpitis requiring endodontic treatment
Presence of fistulas or swelling
Mobile teeth or tenderness to percussion
Anterior teeth with aesthetic concerns
Pregnant women, in view of requirements for radiographs
Patients younger than 18 y
Patients unable to give consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahmed Elkhadem, PhD
Organizational Affiliation
Cairo University
Official's Role
Study Chair
Facility Information:
Facility Name
Omnia Magdy
City
Cairo
ZIP/Postal Code
02
Country
Egypt
12. IPD Sharing Statement
Learn more about this trial
Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions
We'll reach out to this number within 24 hrs